Bendula, Mary Mae T.

HRN: 28-42-07  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/03/2026
CEFTRIAXONE 1G (VIAL)
07/03/2026
07/09/2026
IV
2G
OD
Acute Complicated Pyelonephritis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: